Numerous Data Mining and Drug Design Capabilities Added
Simulations Plus Subsidiary Receives Medicare Accreditation
Highest level of accreditation achieved after on-site inspection
Simulations Plus CEO to Present at Southern California Investor Conference
Presentation to be Webcast
Simulations Plus Releases ADMET Predictor™ Version 4.0
Latest Update to Best-in-Class Software Further Extends Lead over Competition
Simulations Plus Reports Third Quarter FY2009 Financial Results
Best-in-Class Pharmaceutical Software & Services Sales Remain Strong
Simulations Plus Sets Date for Third Quarter Fiscal Year 2009 Earnings Release and Conference Call
Conference Call to Be on Thursday, July 16, at 4:15 PM EDT
Simulations Plus Reports Preliminary Results for Third Fiscal Quarter
Company CEO to Present at New York City Investor Meeting and Webinar
Simulations Plus Announces Change In Acquisition Status
One Pharmaceutical Acquisition Declined, Others Under Investigation
Simulations Plus Appoints Michael Pelekis, PH.D., Director for Business Development
New Position To Focus On Acquisitions And Collaborations
Simulations Plus Wins Phase II, Small Business Innovation Research Grant
$525,000 Grant to Speed Commercialization of Advancements to Company’s Industry-Leading Molecular Property Prediction Software
Simulations Plus Reports Second Quarter FY2009 Financial Results
Continued Growth – Revenues Up 12.7%, Cash Up 20.2%
Simulations Plus Sets Date for Second Quarter Fiscal Year 2009 Earnings Release and Conference Call
Conference Call to be on Wednesday, April 15, at 4:15 PM EDT
Simulations Plus Reports First Quarter FY2009 Financial Results
Company Sets New Record for First Quarter: Revenues up 7.5% and Earnings Up Over 28%
Simulations Plus Sets Date for First Quarter Fiscal Year 2008 Earnings Release and Conference Call
Conference Call to be on Thursday, January 15, at 4:15 PM EST
Simulations Plus Releases ClassPharmer™ Version 4.6
New Version Further Improves Powerful Data Mining and Drug Design Capabilities
Simulations Plus Reports FY2008 Financial Results
Earnings Up 17.7%, Shareholder Equity Up 29.4% Over Previous Fiscal Year